Chemoradiation for Locally Advanced Unresectable Pancreatic Cancer-What Now?

JAMA Oncol. 2017 Jun 1;3(6):850-851. doi: 10.1001/jamaoncol.2016.3012.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Chemoradiotherapy / adverse effects*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Dose Fractionation, Radiation
  • Drug Administration Schedule
  • Erlotinib Hydrochloride / administration & dosage*
  • Erlotinib Hydrochloride / adverse effects
  • Female
  • Gemcitabine
  • Humans
  • Male
  • Middle Aged
  • Mortality
  • Pancreatic Neoplasms / mortality*
  • Pancreatic Neoplasms / therapy*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Deoxycytidine
  • Erlotinib Hydrochloride
  • Gemcitabine